149 related articles for article (PubMed ID: 33877552)
1. Clinicopathologic Characteristics and Survival of Patients with Rare Malignant Ovarian Yolk Sac Tumors: A Population-based Analysis.
Wang T; Wang B; Wang SX; Wu MF
Curr Med Sci; 2021 Apr; 41(2):342-347. PubMed ID: 33877552
[TBL] [Abstract][Full Text] [Related]
2. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
[TBL] [Abstract][Full Text] [Related]
3. Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
Young RH; Wong A; Stall JN
Am J Surg Pathol; 2022 Mar; 46(3):309-325. PubMed ID: 34469331
[TBL] [Abstract][Full Text] [Related]
4. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
[TBL] [Abstract][Full Text] [Related]
5. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
[TBL] [Abstract][Full Text] [Related]
6. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
7. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
8. Yolk sac tumor in postmenopausal patients: pure or associated with adenocarcinoma, a rare phenomenon.
Roma AA; Przybycin CG
Int J Gynecol Pathol; 2014 Sep; 33(5):477-82. PubMed ID: 25083963
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
10. Malignant Brenner tumors of the ovary; a population-based analysis.
Nasioudis D; Sisti G; Holcomb K; Kanninen T; Witkin SS
Gynecol Oncol; 2016 Jul; 142(1):44-49. PubMed ID: 27130406
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Yolk Sac Tumor With High-Grade Serous Carcinoma in a 62-Year-Old Woman.
McCarthy WA; Masand RP
Int J Surg Pathol; 2016 Jun; 24(4):360-5. PubMed ID: 26782153
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Yolk Sac Tumors; Does Age Matter?
Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
[TBL] [Abstract][Full Text] [Related]
13. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: A Second Primary Endodermal Sinus Tumor 9 Years after Initial Diagnosis.
Moukarzel LA; Levinson K; Grumbine FC
J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):259-261. PubMed ID: 27818263
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Siltanen S; Anttonen M; Heikkilä P; Narita N; Laitinen M; Ritvos O; Wilson DB; Heikinheimo M
Am J Pathol; 1999 Dec; 155(6):1823-9. PubMed ID: 10595911
[TBL] [Abstract][Full Text] [Related]
16. Bilateral ovarian mixed epithelial adenocarcinoma in a postmenopausal woman with unilateral ovarian yolk sac tumor component.
Chen Q; Chen X
Int J Clin Exp Pathol; 2014; 7(11):8259-65. PubMed ID: 25550883
[TBL] [Abstract][Full Text] [Related]
17. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
18. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of hepatoid yolk sac tumor in women: what's up, Doc?
Rittiluechai K; Wilcox R; Lisle J; Everett E; Wallace HJ; Verschraegen CF
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():25-9. PubMed ID: 24462393
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
